drugset / Trial / NCT01512901

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

NCT01512901 ↗

Phase 2/3 Completed Santen Pharmaceutical Co., Ltd.

Summary

This study will evaluate the efficacy and safety of Betamethasone Microsphere (DE-102) for macular edema following branch retinal vein occlusion

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Microsphere Unknown — —